Viewing Study NCT05038969


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-01-01 @ 10:17 AM
Study NCT ID: NCT05038969
Status: COMPLETED
Last Update Posted: 2021-09-09
First Post: 2021-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)
Sponsor: Genuine Research Center, Egypt
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GRC/1/20/868
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View